CB Therapeutics

CB Therapeutics is specializing in the biosynthesis of ethically-produced, environmentally-friendly products for human health. The main areas of focus for CB Therapeutics is producing natural molecules in psychedelic medicine, cannabinoid-based therapies and food technologies. Key to the development of high-value compounds for these different areas is the fermentation of simple sugars by yeast. CB Therapeutics uses their proprietary production platform of microorganisms and enzymes to produce a broad range of phytochemicals faster, with less resources, at greater yields, purity, consistency and efficiency than competing platforms. Currently, CB Therapeutics possesses 7 patents covering various bioproduction inventions including optimized genes for psilocybin synthesis.

Jobs: